Equity / Investment · GCC · Announced 14 Oct 2026

Avenzo Pharma → Khazaen Economic City

Avenzo Pharma, part of Oman-based Avicen Group, announced its drug-manufacturing investment in Khazaen Economic City at the Inspire Oman Investors Summit 2026, building on its 2024 RO 20 million lease for a 20,000 m² plot there.

Parties: Avenzo Pharma (Oman) → Khazaen Economic City (Oman)

Value
Undisclosed
Territory
Khazaen Economic City, Oman
Therapeutic area
Other
Asset
Pharmaceutical manufacturing plant
Announced
14 Oct 2026

Our analysis

Why this matters

On 14 October 2026, at the Inspire Oman Investors Summit 2026, organised with the Oman Chamber of Commerce and Industry, Avenzo Pharma announced its investment in drug manufacturing in Khazaen Economic City. The summit report did not give an amount, products or timeline for this announcement.

The project is not new. In early September 2024 Avenzo, a subsidiary of Oman-based Avicen Group, pledged about RO 20 million (about US$50 million) for a generic-drugs manufacturing plant at Khazaen and signed a lease for a 20,000 m² plot, with Oman's Minister of Health attending. Khazaen has since added more investors to its "Medicine City" cluster, including four agreements worth OMR 20 million in November 2026.

The full analysis is free to read with a work email on this page.

Source: Oman Daily

More deals involving Avenzo Pharma or Khazaen Economic City

Latest deals

All GCC deals → · All equity / investment deals → · Browse all emerging-market pharma deals →